Real-world effectiveness and safety of lanadelumab for prophylaxis of hereditary angioedema attacks: 2-year interim results from the enable study

被引：0
作者：
Saguer, I. Martinez [1 ]
Cancian, M. [2 ]
Kinaciyan, T. [3 ]
Kessel, A. [4 ]
Andriotti, T. [5 ]
Botha, J. [6 ]
Wuillemin, W. [7 ,8 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Univ Hosp Padua, Padua, Italy
[3] Med Univ Vienna, Vienna, Austria
[4] Technion Fac Med, Bnai Zion Med Ctr, Haifa, Israel
[5] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Luzerner Kantonsspital, Luzern, Switzerland
[8] Univ Bern, Bern, Switzerland
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000847
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [21] Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study
    Nielsen, Jimmi
    Kane, John M.
    Correll, Christoph U.
    [J]. BIPOLAR DISORDERS, 2012, 14 (08) : 863 - 869
  • [22] Efficacy and safety of Cinryze for the prevention of hereditary angioedema attacks in children: interim results of a Phase 3 study
    Aygoren-Pursun, E.
    Moldovan, D.
    Christensen, J.
    van, Leerberghe A.
    Wu, Y.
    Schranz, J.
    Martinez-Saguer, I
    Soteres, D.
    [J]. ALLERGY, 2016, 71 : 296 - 296
  • [23] P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study
    Sood, Siddhartha
    Rimke, Alexander
    Rankin, Brian
    Abduelmula, Abrahim
    Georgakopoulos, Jorge
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Devani, Alim
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [24] Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
    Craig, Timothy J.
    Zaragoza-Urdaz, Rafael H.
    Li, H. Henry
    Yu, Ming
    Ren, Hong
    Juethner, Salome
    Anderson, John
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01)
  • [25] Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
    Mattingly, G.
    Christensen, M.
    Simonsen, K.
    Hammer-Helmich, L.
    Ren, H.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S341 - S341
  • [26] Quality of life during lanadelumab treatment in patients with hereditary angioedema: 24-month results from the enable study
    Saguer, I. Martinez
    Magerl, M.
    Andriotti, T.
    Botha, J.
    Agmon-Levin, N.
    Watt, M.
    Maurer, M.
    [J]. ALLERGY, 2023, 78 : 26 - 27
  • [27] Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
    Timothy J. Craig
    Rafael H. Zaragoza-Urdaz
    H. Henry Li
    Ming Yu
    Hong Ren
    Salomé Juethner
    John Anderson
    [J]. Allergy, Asthma & Clinical Immunology, 18
  • [28] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Eric L. Simpson
    Ben Lockshin
    Lara Wine Lee
    Zhen Chen
    Moataz Daoud
    Andrew Korotzer
    [J]. Dermatology and Therapy, 2024, 14 : 261 - 270
  • [29] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Simpson, Eric L.
    Lockshin, Ben
    Lee, Lara Wine
    Chen, Zhen
    Daoud, Moataz
    Korotzer, Andrew
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (01) : 261 - 270
  • [30] Lanadelumab reduces high morbidity attacks in patients with hereditary angioedema (HAE): results from the phase 3 HELP study
    Bernstein, J. A.
    Banerji, A.
    Schranz, J.
    Nurse, C.
    Riedl, M.
    Lu, P.
    [J]. ALLERGY, 2018, 73 : 288 - 289
12345